{"entity":{"type":"insider","cik":"0001274412","url":"/insider/0001274412","json_url":"/insider/0001274412.json","name":"ARCH VENTURE PARTNERS VI LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":7,"first":"2013-05-14","last":"2017-12-13","span_basis":"filed_date"},"name_variants":[{"name":"ARCH VENTURE PARTNERS VI LLC","source":"filing","n_filings":7,"first_seen":"2013-05-14","last_seen":"2017-12-13"}],"transactions":[{"id":5350142,"accession":"0001104659-17-073156","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001104659-17-073156","line_url":"/filing/0001104659-17-073156#line-7","is_derivative":false,"issuer_cik":"0001219042","issuer_name":"Quanterix Corp","issuer_ticker":"QTRX","issuer_name_source":null,"issuer_url":"/issuer/0001219042","owner_cik":null,"owner_name":"ARCH Venture Fund VIII Overage, L.P.; BYBEE CLINTON; ARCH VENTURE PARTNERS VI LP; ARCH VENTURE PARTNERS VI LLC; ARCH Venture Partners VIII, LLC; ARCH VENTURE FUND VI LP; NELSEN ROBERT","owner_display_name":"ARCH Venture Fund VIII Overage, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":266000.0,"shares_display":"266,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":3990000.0,"total_display":"3,990,000.00","total_whole":"3,990,000","shares_owned_after":1537684.0,"shares_owned_after_display":"1,537,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-11","filed_date":"2017-12-13","scope":"insider"},{"id":8067244,"accession":"0000899243-15-008449","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-15-008449","line_url":"/filing/0000899243-15-008449#line-2","is_derivative":false,"issuer_cik":"0001031836","issuer_name":"XTERA COMMUNICATIONS, INC.","issuer_ticker":"XCOM","issuer_name_source":null,"issuer_url":"/issuer/0001031836","owner_cik":null,"owner_name":"ARCH VENTURE PARTNERS VI LP; ARCH ENTREPRENEURS FUND LP; ARCH VENTURE FUND IV L P; ARCH VENTURE PARTNERS LLC; ARCH VENTURE FUND VI LP; ARCH VENTURE FUND IVA LP; ARCH VENTURE PARTNERS VI LLC; ARCH VENTURE FUND III L P; CRANDELL KEITH; ARCH VENTURE PARTNERS IV LLC","owner_display_name":"ARCH VENTURE PARTNERS VI LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","total_whole":"1,500,000","shares_owned_after":1885090.0,"shares_owned_after_display":"1,885,090","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-11-17","filed_date":"2015-11-18","scope":"insider"},{"id":8781612,"accession":"0001140361-15-038785","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-038785","line_url":"/filing/0001140361-15-038785#line-1","is_derivative":false,"issuer_cik":"0001219039","issuer_name":"ADESTO TECHNOLOGIES Corp","issuer_ticker":"IOTS","issuer_name_source":null,"issuer_url":"/issuer/0001219039","owner_cik":null,"owner_name":"CRANDELL KEITH; NELSEN ROBERT; ARCH VENTURE PARTNERS VI LLC; BYBEE CLINTON; ARCH VENTURE PARTNERS VI LP; ARCH VENTURE FUND VI LP","owner_display_name":"CRANDELL KEITH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":2000000.0,"total_display":"2,000,000.00","total_whole":"2,000,000","shares_owned_after":400000.0,"shares_owned_after_display":"400,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-26","filed_date":"2015-10-28","scope":"insider"},{"id":8440787,"accession":"0001104659-15-013152","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-013152","line_url":"/filing/0001104659-15-013152#line-1","is_derivative":false,"issuer_cik":"0001219039","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001219039","owner_cik":null,"owner_name":"CRANDELL KEITH; ARCH VENTURE FUND VI LP; ARCH VENTURE PARTNERS VI LLC; ARCH VENTURE PARTNERS VI LP; BYBEE CLINTON","owner_display_name":"CRANDELL KEITH","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":212666.0,"shares_display":"212,666","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":2551992.0,"total_display":"2,551,992.00","total_whole":"2,551,992","shares_owned_after":965660.0,"shares_owned_after_display":"965,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-19","filed_date":"2015-02-23","scope":"insider"},{"id":6783184,"accession":"0001012975-14-000328","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001012975-14-000328","line_url":"/filing/0001012975-14-000328","is_derivative":false,"issuer_cik":"0001219039","issuer_name":"Receptos, Inc.","issuer_ticker":"RCPT","issuer_name_source":null,"issuer_url":"/issuer/0001219039","owner_cik":null,"owner_name":"ARCH VENTURE FUND VI LP; ARCH Venture Partners VII, L.P.; BYBEE CLINTON; Arch Venture Fund VII LP; NELSEN ROBERT; ARCH VENTURE PARTNERS VI LLC; CRANDELL KEITH; ARCH Venture Partners VII, LLC; ARCH VENTURE PARTNERS VI LP","owner_display_name":"ARCH VENTURE FUND VI LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8395.0,"shares_display":"8,395","price_per_share":28.39,"price_display":"28.39","price_state":"stated","total_value":238334.05,"total_display":"238,334.05","total_whole":"238,334","shares_owned_after":2058634.0,"shares_owned_after_display":"2,058,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-14","filed_date":"2014-05-15","scope":"insider","n_lines":2},{"id":6783174,"accession":"0001012975-14-000328","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001012975-14-000328","line_url":"/filing/0001012975-14-000328","is_derivative":false,"issuer_cik":"0001219039","issuer_name":"Receptos, Inc.","issuer_ticker":"RCPT","issuer_name_source":null,"issuer_url":"/issuer/0001219039","owner_cik":null,"owner_name":"ARCH VENTURE FUND VI LP; ARCH Venture Partners VII, L.P.; BYBEE CLINTON; Arch Venture Fund VII LP; NELSEN ROBERT; ARCH VENTURE PARTNERS VI LLC; CRANDELL KEITH; ARCH Venture Partners VII, LLC; ARCH VENTURE PARTNERS VI LP","owner_display_name":"ARCH VENTURE FUND VI LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36986.0,"shares_display":"36,986","price_per_share":29.94570810576975,"price_display":"29.95","price_state":"stated","total_value":1107571.96,"total_display":"1,107,571.96","total_whole":"1,107,572","shares_owned_after":2066541.0,"shares_owned_after_display":"2,066,541","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-13","filed_date":"2014-05-15","scope":"insider","n_lines":4},{"id":4551102,"accession":"0001181431-13-052844","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-13-052844","line_url":"/filing/0001181431-13-052844#line-4","is_derivative":false,"issuer_cik":"0001219039","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001219039","owner_cik":null,"owner_name":"CRANDELL KEITH; ARCH VENTURE PARTNERS VI LLC; ARCH VENTURE PARTNERS VI LP; ARCH VENTURE FUND VI LP; BYBEE CLINTON","owner_display_name":"CRANDELL KEITH","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":833333.0,"shares_display":"833,333","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":4999998.0,"total_display":"4,999,998.00","total_whole":"4,999,998","shares_owned_after":2473188.0,"shares_owned_after_display":"2,473,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-04","filed_date":"2013-10-07","scope":"insider"},{"id":5006183,"accession":"0001104659-13-041516","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-13-041516","line_url":"/filing/0001104659-13-041516#line-4","is_derivative":false,"issuer_cik":"0001219039","issuer_name":"Receptos, Inc.","issuer_ticker":"RCPT","issuer_name_source":null,"issuer_url":"/issuer/0001219039","owner_cik":null,"owner_name":"Arch Venture Fund VII LP; ARCH Venture Partners VII, L.P.; ARCH VENTURE FUND VI LP; BYBEE CLINTON; NELSEN ROBERT; ARCH Venture Partners VII, LLC; CRANDELL KEITH; ARCH VENTURE PARTNERS VI LP; ARCH VENTURE PARTNERS VI LLC","owner_display_name":"Arch Venture Fund VII LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":284485.0,"shares_display":"284,485","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":3982790.0,"total_display":"3,982,790.00","total_whole":"3,982,790","shares_owned_after":2101376.0,"shares_owned_after_display":"2,101,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-14","filed_date":"2013-05-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001503274","name":"Quanterix Corp","url":"/issuer/0001503274","role":"Ten percent owner","n_filings":1,"first_seen":"2017-12-13","last_seen":"2017-12-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001122051","name":"XTERA COMMUNICATIONS, INC.","url":"/issuer/0001122051","role":"Ten percent owner","n_filings":1,"first_seen":"2015-11-18","last_seen":"2015-11-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001395848","name":"ADESTO TECHNOLOGIES Corp","url":"/issuer/0001395848","role":"Ten percent owner","n_filings":1,"first_seen":"2015-10-28","last_seen":"2015-10-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001600132","name":"Bellerophon Therapeutics, Inc.","url":"/issuer/0001600132","role":"Ten percent owner","n_filings":1,"first_seen":"2015-02-23","last_seen":"2015-02-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001463729","name":"Receptos, Inc.","url":"/issuer/0001463729","role":"Ten percent owner","n_filings":2,"first_seen":"2013-05-14","last_seen":"2014-05-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001434316","name":"FATE THERAPEUTICS INC","url":"/issuer/0001434316","role":"Ten percent owner","n_filings":1,"first_seen":"2013-10-07","last_seen":"2013-10-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001274412","retrieved_at":"2026-08-26T22:17:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}